Evidence map›Paper›PMID 10569777›Full record

ArticleInfection and immunity1999

Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection.

D A Haake, M K Mazel, A M McCoy, F Milward, G Chao, J Matsunaga, E A Wagar

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 270 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Advances in the development of a vaccine for the prevention of human leptospirosis: a review.Revista do Instituto de Medicina Tropical de Sao Paulo · 2026
    Review
  5. Article
  6. Review
  7. Evaluation ofFrontiers in microbiology · 2023
    Article
  8. Tropical medicine and infectious disease · 2022
    Article
  9. Tropical medicine and infectious disease · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Vaccination WithFrontiers in cellular and infection microbiology · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

D A HaakeDivision of Infectious Diseases, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California 90073, USA. dhaake@ucla.edu
M K Mazel
A M McCoy
F Milward
G Chao
J Matsunaga
E A Wagar
VA Greater Los Angeles Healthcare System · USUniversity of California, Los Angeles · US

Funding

Outer Membrane Proteins of Pathogenic Leptospira SpeciesR01AI034431 · NIAID · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI GOMES-SOLECKI, MARIA, HAAKE, DAVID A · 2003 to 2015
$4.1M
OUTER MEMBRANE PROTEINS OF PATHOGENIC LEPTOSPIRA SPECIESR21AI034431 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HAAKE, DAVID A · 2001 to 2001
$252k
OUTER MEMBRANE PROTEINS OF PATHOGENIC LEPTOSPIRA SPECIESR29AI034431 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HAAKE, DAVID A · 1996 to 2000
$91k
NIAID NIH HHS AI34431NIAID NIH HHS R01 AI034431NIAID NIH HHS R21 AI034431NIAID NIH HHS R29 AI034431
6 · The paper itself

Abstract

New vaccine strategies are needed for prevention of leptospirosis, a widespread human and veterinary disease caused by invasive spirochetes belonging to the genus Leptospira. We have examined the immunoprotective capacity of the leptospiral porin OmpL1 and the leptospiral outer membrane lipoprotein LipL41 in the Golden Syrian hamster model of leptospirosis. Specialized expression plasmids were developed to facilitate expression of leptospiral proteins in Escherichia coli as the membrane-associated proteins OmpL1-M and LipL41-M. Although OmpL1-M expression is highly toxic in E. coli, this was accomplished by using plasmid pMMB66-OmpL1, which has undetectable background expression without induction. LipL41-M expression and processing were enhanced by altering its lipoprotein signal peptidase cleavage site to mimic that of the murein lipoprotein. Active immunization of hamsters with E. coli membrane fractions containing a combination of OmpL1-M and LipL41-M was found to provide significant protection against homologous challenge with Leptospira kirschneri serovar grippotyphosa. At 28 days after intraperitoneal inoculation, survival in animals vaccinated with both proteins was 71% (95% confidence interval [CI], 53 to 89%), compared with only 25% (95% CI, 8 to 42%) in the control group (P < 0.001). On the basis of serological, histological, and microbiological assays, no evidence of infection was found in the vaccinated survivors. The protective effects of immunization with OmpL1-M and LipL41-M were synergistic, since significant levels of protection were not observed in animals immunized with either OmpL1-M or LipL41-M alone. In contrast to immunization with the membrane-associated forms of leptospiral proteins, hamsters immunized with His(6)-OmpL1 and His(6)-LipL41 fusion proteins, either alone or in combination, were not protected. These data indicate that the manner in which OmpL1 and LipL41 associates with membranes is an important determinant of immunoprotection.

Indexed as

ImmunizationAnimalsAntibodies, BacterialBacterial Outer Membrane ProteinsCricetinaeDisease Models, AnimalLeptospiraLeptospirosisLethal Dose 50MesocricetusRecombinant Fusion ProteinsRecombinant ProteinsAntibodies, BacterialBacterial Outer Membrane ProteinsompL1 protein, LeptospiraRecombinant Fusion ProteinsRecombinant Proteins

Identifiers

PMID10569777
PMCPMC97069
OpenAlexW2128682436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.